Expertise in
11
conditions

Hans Eiskjaer

Palle Juul Jensens Boulevard 99, 
Aarhus N, DK 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
11
conditions
Palle Juul Jensens Boulevard 99, 
Aarhus N, DK 

Overview

Hans Eiskjaer practices practicing medicine in Aarhus N, Denmark.

Mr. Eiskjaer is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Heart Failure, Cardiac Arrest, Cardiogenic Shock, Heart Transplant, and Lung Transplant.

He is actively involved in clinical research, co-authoring 167 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Palle Juul Jensens Boulevard 99, Aarhus N, 8200, Denmark
Other Locations
Palle Juul Jensens Boulevard 82, Aarhus N, 8200, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

DAPARHT: DAPAgliflozin for Renal Protection in Heart Transplant Recipients
DAPARHT: DAPAgliflozin for Renal Protection in Heart Transplant Recipients
Enrollment Status: Recruiting
Publish Date: October 03, 2024
Intervention Type: Drug
Study Phase: Phase 3
Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial
Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Device
Study Phase: Not Applicable
5, 6 or 7 Year Follow-up Control After the SCHEDULE Study (SCANDINAVIAN HEART TRANSPLANT EVEROLIMUS DE NOVO STUDY WITH EARLY CNI AVOIDANCE)
5, 6 or 7 Year Follow-up Control After the SCHEDULE Study (SCANDINAVIAN HEART TRANSPLANT EVEROLIMUS DE NOVO STUDY WITH EARLY CNI AVOIDANCE)
Enrollment Status: Completed
Publish Date: October 03, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trial

167 Total Publications

Time to let go of the biopsy? A new era in cardiac rejection monitoring?
Time to let go of the biopsy? A new era in cardiac rejection monitoring?
Journal: JHLT open
Published: February 09, 2026

Frequently Asked Questions about Hans Eiskjaer

Is Hans Eiskjaer a top-rated expert for Heart Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Hans Eiskjaer is classified as an Elite expert for Heart Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hans Eiskjaer participate in research or clinical trials?

Yes. Hans Eiskjaer has published 167 articles and abstracts on conditions like Heart Transplant. You can view a list of Hans Eiskjaer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Eiskjaer's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 11 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile